Biochimica et Biophysica Acta. International Journal of Biochemistry and Biophysics 1998: Vol 1400 Table of Contents

1 Pages·1998·0.18 MB·English

BBIOCHIMIBCA E!T BIOPH YSICA ACTA
Gene Structure and Expression
él) Vol. 1400, No. 1-3: 1 October 1998
ELSEVIER
Contents
BBA is cited in: Current Contents! Life Sciences - Biological - Chemical Abstracts - Index Chemicus - Index Medicus! MEDLINE
Cambridge Scientific Abstracts (CSA) - EMBASE/Excerpta Medica - Reference Update - Elsevier BIOBASE!/Current Awarene os in Biological Sciences
Information for Contributors Cell death induced by topoisomerase-targeted drugs:
more questions than answers
Reviews S.H. Kaufmann (USA)
Mutagenic properties of topoisomerase-targeted drugs
Preface B.C. Baguley and L.R. Ferguson (New Zealand)
Structure of DNA topoisomerases The response of eukaryotic topoisomerases to DNA
J.M. Berger (USA) damage
Bacterial and archeal type I topoisomerases P.S. Kingma and N. Osheroff (USA)
Y.-C. Tse-Dinh (USA) Secondary leukemias induced by topoisomerase-targeted
DNA gyrase and topoisomerase IV: biochemical activ- drugs
ities, physiological roles during chromosome replica- C.A. Felix (USA)
tion, and drug sensitivities Cellular resistance to topoisomerase-targeted drugs:
C. Levine, H. Hiasa and K.J. Marians (USA) from drug uptake to cell death
Clinical applications of quinolones A.K. Larsen and A. Skladanowski (France, Po-
D.C. Hooper (USA) land)
Investigating the biological functions of DNA topoiso- Clinical resistance to topoisomerase-targeted drugs
merases in eukaryotic cells A.-M.C. Dingemans, H.M. Pinedo and G. Giaccone
J.L. Nitiss (USA) (The Netherlands)
Mechanism of action of eukaryotic DNA topoisomerase Yeast as a model organism for studying the actions of
I and drugs targeted to the enzyme DNA topoisomerase-targeted drugs
Y. Pommier, P. Pourquier, Y. Fan and D. Strumberg R.J.D. Reid, P. Benedetti and M.-A. Bjornsti (Italy,
(USA) USA)
Clinical applications of the camptothecins Animal models for studying the action of topoisomerase
C.H. Takimoto, J. Wright and S.G. Arbuck (USA) I targeted drugs
Physiological regulation of eukaryotic topoisomerase II J. Thompson, C.F. Stewart and P.J. Houghton
R.J. Isaacs, S.L. Davies, M.I. Sandri, C. Redwood, (USA)
N.J. Wells and 1.D. Hickson (UK) Vaccinia virus DNA topoisomerase: a model eukaryotic
Mechanism of action of eukaryotic topoisomerase II and type IB enzyme
drugs targeted to the enzyme S. Shuman (USA)
D.A. Burden and N. Osheroff (USA) Bacteriophage T4, a model system for understanding the
Catalytic inhibitors of DNA topoisomerase II mechanism of type II topoisomerase inhibitors
T. Andoh and R. Ishida (Japan) K.N. Kreuzer (USA)
Clinical applications of anticancer drugs targeted to DNA topoisomerases: a new twist for antiparasitic che-
topoisomerase II motherapy?
K.R. Hande (USA) E.C. Nenortas, A. L. Bodley and T.A. Shapiro
DNA sequence selectivity of topoisomerases and topo- (USA)
isomerase poisons
G. Capranico and M. Binaschi (Italy) Author Index